Alprazolam Tablet 0.5 mg (Alprazolam)

Adult dose

To achieve the greatest benefit, determine the dose for each individual. The usual daily doses listed below are suitable for most patients, but higher doses may be required. In such cases, increase the dose gradually to avoid adverse effects. The risk of dependence may increase with the dose and duration of treatment. Therefore, administer the lowest effective dose for the shortest possible period and frequently reassess the need to continue treatment. ○ Adults 1. As the initial dose, administer 0.25-0.5㎎ of alprazolam per dose 3 times daily, with a maximum dose of 4㎎ per day. For elderly patients, patients with hepatic impairment, and debilitated patients, the initial dose is 0.25㎎ per dose 2-3 times daily. Reduce the dose if adverse effects occur at the initial dose. 2. Psychosomatic disorders Administer 1.2㎎ of this medicine per day orally in 3 divided doses. If increasing the dose, increase it gradually up to a maximum of 2.4㎎ per day and administer orally in 3-4 divided doses. For elderly patients, the initial dose is 0.4㎎ per dose 1-2 times daily, with a maximum dose of 1.2㎎ per day. 3. Panic disorder Start with an initial dose of 0.5㎎ of this medicine and, depending on the patient's response to treatment, increase the dose by no more than 1㎎ at intervals of 3-4 days, to an average total daily dose of 5-6㎎ administered in 3-4 divided doses. When discontinuing treatment, reduce the dose by no more than 0.5㎎, usually at 3-day intervals; a slower reduction may be necessary in some cases.

This medication is a benzodiazepine that acts on the central nervous system to relieve anxiety and facilitate sedation. Taking this medication with narcotics can inhibit breathing, potentially leading to coma or death, so it should only be used with the minimum effective dose and duration when absolutely necessary. This medication carries a risk of misuse, so the patient's condition should be regularly monitored according to the physician's instructions during treatment, and any remaining medication must be stored and disposed of safely to prevent misuse. Patients with allergic reactions or certain conditions, such as acute angle-closure glaucoma, severe myasthenia gravis, severe respiratory failure, or severe liver dysfunction, should not take this medication. Patients with heart, liver, or kidney issues, elderly patients, or frail patients should use this medication cautiously, and extra caution is needed for those with a history of allergies. This medication can cause withdrawal symptoms, so do not discontinue abruptly but gradually reduce the dosage under the guidance of a physician. Drowsiness and decreased concentration may occur during treatment; therefore, avoid driving or operating dangerous machinery. Also, this medication can have enhanced sedative effects when taken with other central nervous system depressants or alcohol, so care should be taken not to take them together. During pregnancy, especially in the last three months, it should be avoided as it may affect the fetus, and breastfeeding should also be avoided or breastfeeding should be suspended if possible. Safety for children and adolescents under 18 years has not been established, so usage is not recommended. In case of overdose, severe drowsiness, movement disorders, coma, and respiratory depression may occur, and immediate medical treatment should be sought. Keep this medication out of reach of children, ensuring it is stored in its original packaging to prevent quality deterioration.

• Mild discomfort
• insomnia
• abdominal and muscle cramps
• vomiting
• sweating
• trembling
• convulsions
• seizures
• agitation
• increased muscle rigidity

Store this medication in a tightly closed container that does not allow light in, ideally at room temperature. Proper storage helps maintain the medication's effectiveness and prevents degradation.

Appearance

Light orange oval tablets

Package unit

30 tablets/bottle, 200 tablets/bottle, 200 tablets (10 tablets/PTP × 20)